Study: Statin use reduces risk of colon cancer

Research presented at the American College of Gastroenterology meeting suggests that the use of statins may lower the risk of colon cancer.

A meta-analysis of 22 studies involving more than 2.5 million people showed that those taking statins had a 12-percent lower risk of developing colon cancer, compared to those who did not take the drugs. The research suggested that the longer people took the cholesterol-lowering drugs, the lower their risk of later developing the disease.

Lead researcher, Jewel Samadder, noted that the "findings suggest that randomised controlled trials designed to test the hypothesis that statins reduce the risk of colorectal cancer are warranted." The use of statins has also been associated with the reduced risk of several other cancers, including breast, prostate, lung, pancreas, and liver cancer.

To read more Top Story articles, click here.